# 40P Efficacy and safety of immune checkpoint inhibitors in previously treated metastatic non-small cell lung cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/40p-efficacy-and-safety-of-immune-checkpoint-inhibitors-in-previously-treated/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Renato Cunha,Mauricio Fernandes,Sofia Abreu,Cristina Oliveira,Josiane Mourão Dias,Susana P. Alves,Ana Rodrigues,Jorge Oliveira,Montserrat Pousa,Marta Soares,Isabel Azevedo |
| Citations | 0 |
| DOI | 10.1016/j.annonc.2020.10.527 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3111824584 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Mauricio Fernandes](https://scholariq.org/researchers/mauricio-fernandes/)

## Paper journal

- [Annals of Oncology](https://scholariq.org/journals/annals-of-oncology/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.